The involvement of high mobility group 1 cytokine and phospholipases A2 in diabetic retinopathy

Lipids in Health and Disease

Volumn 13, Issue 1, 2014, Pages

  Gong, Yan ^a   Jin, Xin ^a   Wang, Quan Shun ^b   Wei, Shi Hui ^a   Hou, Bao Ke ^a   Li, Hong Yang ^a   Zhang, Mao Nian ^a   Li, Zhao Hui ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b Chinese People's Armed Police Force General Hospital   (China)

Author keywords

Blood retinal barrier; Endothelial cells; Micro vessels; Retinal pericytes

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; HIGH MOBILITY GROUP B1 PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; PHOSPHOLIPASE A2; STREPTOZOCIN; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; CHEMOKINE; HBP1 PROTEIN, RAT; MEMBRANE PROTEIN; PTGS1 PROTEIN, RAT; PTGS2 PROTEIN, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD RETINA BARRIER; CELL DEATH; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; DISEASE MODEL; ENDOTHELIUM INJURY; MALE; MEMBRANE DAMAGE; MICROVASCULATURE; NONHUMAN; PERICYTE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; RETINA BLOOD VESSEL; RETINAL TISSUE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; UPREGULATION; ANIMAL; APOPTOSIS; COMPLICATION; ENZYMOLOGY; EXPERIMENTAL DIABETES MELLITUS; GENE EXPRESSION; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; RETINA GANGLION CELL; SPRAGUE DAWLEY RAT;

ANIMALS; APOPTOSIS; CHEMOKINES; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; GENE EXPRESSION; HMGB1 PROTEIN; MALE; MEMBRANE PROTEINS; PERICYTES; PHOSPHOLIPASES A2; RATS, SPRAGUE-DAWLEY; RETINAL GANGLION CELLS; RETINAL VESSELS;

EID: 84976871554     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-13-156     Document Type: Article

References (32)

1. Antonetti DA, Klein R, Gardner TW: Diabetic retinopathy. N Engl J Med 2012, 366: 1227-1239. 10.1056/NEJMra1005073
2. International Diabetes Federation: IDF Diabetes Atlas. 6th edition. Brussels, Belgium: International Diabetes Federation; 2013. http://www.idf.org/diabetesatlas
3. Cheung N, Mitchell P, Wong TY: Diabetic retinopathy. Lancet 2010, 376: 124-136. 10.1016/S0140-6736(09)62124-3
4. Dvoriantchikova G, Hernandez E, Grant J, Santos AR, Yang H, Ivanov D: The high-mobility group box-1 nuclear factor mediates retinal injury after ischemia reperfusion. Invest Ophthalmol Vis Sci 2011, 52: 7187-7194. 10.1167/iovs.11-7793
5. van Beijnum JR, Buurman WA, Griffioen AW: Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1). Angiogenesis 2008, 11: 91-99. 10.1007/s10456-008-9093-5
6. Anfuso CD, Assero G, Lupo G, Nicotra A, Cannavo G, Strosznajder RP, Rapisarda P, Pluta R, Alberghina M: Amyloid beta(1-42) and its beta(25-35) fragment induce activation and membrane translocation of cytosolic phospholipase A2 in bovine retina capillary pericytes. Biochim Biophys Acta 2004, 1686: 125-138. 10.1016/j.bbalip.2004.09.006
7. Nicotra A, Lupo G, Giurdanella G, Anfuso CD, Ragusa N, Tirolo C, Marchetti B, Alberghina M: MAPKs mediate the activation of cytosolic phospholipase A2 by amyloid beta(25-35) peptide in bovine retina pericytes. Biochim Biophys Acta 2005, 1733: 172-186. 10.1016/j.bbalip.2004.12.017
8. Singh NK, Hansen DE 3rd, Kundumani-Sridharan V, Rao GN: Both Kdr and Flt1 play a vital role in hypoxia-induced Src-PLD1-PKCg-cPLA(2) activation and retinal neovascularization. Blood 2013, 121: 1911-1923. 10.1182/blood-2012-03-419234
9. Kajdaniuk D, Marek B, Foltyn W, Kos-Kudła B: Vascular endothelial growth factor (VEGF) - Part 1: In physiology and pathophysiology. Endokrynol Pol 2011, 62: 444-455.
10. Hammes HP, Lin J, Renner O, Shani M, Lundqvist A, Betsholtz C, Brownlee M, Deutsch U: Pericytes and the pathogenesis of diabetic retinopathy. Diabetes 2002, 51: 3107-3112. 10.2337/diabetes.51.10.3107
11. Joussen AM, Poulaki V, Le ML, Koizumi K, Esser C, Janicki H, Schraermeyer U, Kociok N, Fauser S, Kirchhof B, Kern TS, Adamis AP: A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J 2004, 18: 1450-1452.
12. Joussen AM, Doehmen S, Le ML, Koizumi K, Radetzky S, Krohne TU, Poulaki V, Semkova I, Kociok N: TNF alpha mediated apoptosis plays an important role in the development of early diabetic retinopathy and long-term histopathological alterations. Mol Vis 2009, 15: 1418-1428.
13. Giurdanella G, Motta C, Muriana S, Arena V, Anfuso CD, Lupo G, Alberghina M: Cytosolic and calcium-independent phospholipase A2 mediate glioma enhanced proangiogenic activity of brain endothelial cells. Microvasc Res 2011, 81: 1-17. 10.1016/j.mvr.2010.11.005
14. Lupo G, Anfuso CD, Ragusa N, Strosznajder RP, Walski M, Alberghina M: t-Butyl hydroperoxide and oxidized low density lipoprotein enhance phospholipid hydrolysis in lipopolysaccharide-stimulated retinal pericytes. Biochim Biophys Acta 2001, 1531: 143-155. 10.1016/S1388-1981(01)00102-0
15. Gavrieli Y, Gavrieli Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992, 119: 493-501. 10.1083/jcb.119.3.493
16. Bucolo C, Leggio GM, Drago F, Salomone S: Eriodictyol prevents early retinal and plasma abnormalities in streptozotocin-induced diabetic rats. Biochem Pharmacol 2012, 84: 88-92. 10.1016/j.bcp.2012.03.019
17. Elanchezhian R, Palsamy P, Madson CJ, Lynch DW, Shinohara T: Age-related cataracts: homocysteine coupled endoplasmic reticulum stress and suppression of Nrf2-dependent antioxidant protection. Chem Biol Interact 2012, 200: 1-10. 10.1016/j.cbi.2012.08.017
18. Fong DS, Aiello L, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris FL 3rd, Klein R: Retinopathy in diabetes. Diabetes Care 2004, 27(1):S84-S87.
19. Ferrara N: Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 2004, 25: 581-611. 10.1210/er.2003-0027
20. El-Asrar AM, Missotten L, Geboes K: Expression of high-mobility groups box-1/receptor for advanced glycation end products/osteopontin/early growth response-1 pathway in proliferative vitreoretinal epiretinal membranes. Mol Vis 2011, 17: 508-518.
21. Abu El-Asrar AM, Nawaz MI, Kangave D, Abouammoh M, Mohammad G: High-mobility group box-1 and endothelial cell angiogenic markers in the vitreous from patients with proliferative diabetic retinopathy. MediatoInflamm 2012, 2012: 697489.
22. Sims GP, Rowe DC, Rietdijk ST, Herbst R, Coyle AJ: HMGB1 and RAGE in inflammation and cancer. Annu Rev Immunol 2010, 28: 367-388. 10.1146/annurev.immunol.021908.132603
23. Lin Q, Yang XP, Fang D, Ren X, Zhou H, Fang J, Liu X, Zhou S, Wen F, Yao X, Wang JM, Su SB: High-mobility group box-1 mediates toll-like receptor 4-dependent angiogenesis. Arterioscler Thromb Vasc Biol 2011, 31: 1024-1032. 10.1161/ATVBAHA.111.224048
24. Wang J, Kolko M: Phospholipases A2 in ocular homeostasis and diseases. Biochimie 2010, 92: 611-619. 10.1016/j.biochi.2010.04.007
25. Kolko M, Wang J, Zhan C, Poulsen KA, Prause JU, Nissen MH, Heegaard S, Bazan NG: Identification of intracellular phospholipases A2 in the human eye: involvement in phagocytosis of photoreceptor outer segments. Invest Ophthalmol Vis Sci 2007, 48: 1401-1409. 10.1167/iovs.06-0865
26. Pannicke T, Iandiev I, Wurm A, Uckermann O, vom Hagen F, Reichenbach A, Wiedemann P, Hammes HP, Bringmann A: Diabetes alters osmotic swelling characteristics and membrane conductance of glial cells in rat retina. Diabetes 2006, 55: 633-639. 10.2337/diabetes.55.03.06.db05-1349
27. Barnett JM, McCollum GW, Penn JS: Role of cytosolic phospholipase A(2) in retinal neovascularization. Invest Ophthalmol Vis Sci 2009, 51: 1136-1142.
28. Salomone S, Waeber C: Selectivity and specificity of sphingosine-1-phosphate receptor ligands: caveats and critical thinking in characterizing receptormediated effects. Front Pharmacol 2011, 2: 9.
29. Noda K, Nakao S, Ishida S, Ishibashi T: Leukocyte adhesion molecules in diabetic retinopathy. J Ophthalmol 2012, 2012: 279037.
30. Witmer AN, Blaauwgeers HG, Weich HA, Alitalo K, Vrensen GF, Schlingemann RO: Altered expression patterns of VEGF receptors in human diabetic retina and in experimental VEGF-induced retinopathy in monkey. Invest Ophthalmol Vis Sci 2002, 43: 849-857.
31. Greenberg JI, Shields DJ, Barillas SG, Acevedo LM, Murphy E, Huang J, Scheppke L, Stockmann C, Johnson RS, Angle N, Cheresh DA: A role for VEGF as a negative regulator of pericyte function and vessel maturation. Nature 2008, 456: 809-813. 10.1038/nature07424
32. Bergers G, Song S: The role of pericytes in blood-vessel formation and maintenance. Neuro Oncol 2005, 7: 452-464. 10.1215/S1152851705000232